These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12214155)

  • 41. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function.
    Adams MJ; Irish AB; Watts GF; Oostryck R; Dogra GK
    Thromb Res; 2008; 123(2):374-80. PubMed ID: 18486198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
    Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
    J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. General changes in hemostasis in gastric cancer.
    Kovacova E; Kinova S; Duris I; Remkova A
    Bratisl Lek Listy; 2009; 110(4):215-21. PubMed ID: 19507648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms.
    Joop K; Berckmans RJ; Nieuwland R; Berkhout J; Romijn FP; Hack CE; Sturk A
    Thromb Haemost; 2001 May; 85(5):810-20. PubMed ID: 11372673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vessel-platelet and coagulation components of hemostasis in patients with chronic tubulointerstitial nephritis].
    Suvorova TS; Tov NL; Movchan EA
    Ter Arkh; 2007; 79(6):56-60. PubMed ID: 17684969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
    Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
    Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
    Eivindson M; Nielsen JN; Grønbaek H; Flyvbjerg A; Hey H
    Horm Res; 2005; 64(1):9-15. PubMed ID: 16088202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases TAFIa level in patients with IBD.
    Owczarek D; Undas A; Foley JH; Nesheim ME; Jabłonski K; Mach T
    J Crohns Colitis; 2012 Feb; 6(1):13-20. PubMed ID: 22261523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
    Smith CJ; Haire WD; Kaufman SS; Mack DR
    Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Assessment of the hemostatic system in healthy preterm and fullterm newborns].
    Pinacho A; Páramo JA
    Rev Med Univ Navarra; 1993; 38(2):23-30. PubMed ID: 14735720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system.
    Danese S; Papa A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):826-8. PubMed ID: 18794594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between hemostatic markers and platelet indices in patients with aortic aneurysm.
    Ihara A; Matsumoto K; Kawamoto T; Shouno S; Kawamoto J; Katayama A; Yoshitatsu M; Izutani H
    Pathophysiol Haemost Thromb; 2006; 35(6):451-6. PubMed ID: 17565239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
    van der Pas R; de Bruin C; Leebeek FW; de Maat MP; Rijken DC; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Lamberts SW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1303-10. PubMed ID: 22278425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
    Koutroubakis IE
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Blood coagulation activation in patients with ulcerative colitis].
    Swiatkowski M; Grad K; Kłopocka M; Budzyński J; Zekanowska E; Kotschy M
    Pol Arch Med Wewn; 2000; 103(1-2):47-51. PubMed ID: 11236258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.